Cart
sales@molnova.com
Isovitexin 7-O-rutinoside
CAS No. 212271-10-8
Isovitexin 7-O-rutinoside( ——— )
Catalog No. M38565 CAS No. 212271-10-8
Isovitexin 7-O-rutinoside is an anti-inflammatory agent that can be isolated from the Mongolian anti-hepatic plant Dianthus versicolor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsovitexin 7-O-rutinoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsovitexin 7-O-rutinoside is an anti-inflammatory agent that can be isolated from the Mongolian anti-hepatic plant Dianthus versicolor.
-
DescriptionIsovitexin 7-O-rutinoside is an anti-inflammatory agent that can be isolated from the Mongolian anti-hepatic plant Dianthus versicolor.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number212271-10-8
-
Formula Weight740.66
-
Molecular FormulaC33H40O19
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Obmann A, et al. Flavonoid C-and O-glycosides from the Mongolian medicinal plant Dianthus versicolor FischJ. Carbohydrate research, 2011, 346(13): 1868-1875.?
molnova catalog
related products
-
Methyl 2,6-dichlorob...
Methyl 2,6-dichlorobenzoate is a biochemical compound that is used for proteomics research.
-
7-Hydroxy-aristolact...
CDK2-IN-15 (Compound 19) is an inhibitor of CDK2 with an IC50 of 2.9 μM. CDK2-IN-15 can be used for cancer research.
-
KIRA6
KIRA6 is an effective inhibitor of IRE1α RNase kinase (IC50: 0.6 μM). It can trigger an apoptotic response.KIRA6 (10-1000 nM, 72 hours) strongly compromises the viability of the KIT-dependent cell line HMC-1.1 at the low nM concentration, in a manner that coincided with KIT blockade.
